Gene set enrichment analysis (GSEA) verified a profound effect on gene sets driven by the MYC family; in particular the MYCN-157 signature of genes associated with poor prognosis in NB (34) was profoundly affected. The gene discussed is MYCN; the disease is neuroblastoma.